Brand hub

Glenmark Pharmaceuticals Inc., USA Recalls

3 recalls found for Glenmark Pharmaceuticals Inc., USA. Check current safety alerts and related brands before using affected products.

HIGH

FDA DRUG

Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

May 27, 2026

ALYACEN 1/35

Failed Impurities/Degradation

Health & Personal Care

HIGH

FDA DRUG

Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe

Nov 21, 2025

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE

Cross Contamination

Health & Personal Care

HIGH

FDA DRUG

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Aug 6, 2025

CARVEDILOL

CGMP Deviations:

Total Recalls

Pages